Now why does that voice sound familiar, I wonder?
Printable View
Now why does that voice sound familiar, I wonder?
To rebut with actual facts, however, they have $3m in working capital, a pipeline of product launches, and sales increased by 59% in the last 6 months alone. They also repeated that their expectations remain to move to profitable operations. It was unclear exactly what time line is in question, but they said they expected significant sales growth over the next 6 to 18 months (p4).
As I have also pointed out, the future remains unknown, as always for BLT to date. I have never recommended that anyone buy BLT or sell it, and I feel pretty confident that I never will. I come here only to discuss publicly available facts, that's all. Yes I own BLT shares myself, and others have always put counter arguments, many of which were recently deleted by the poster though.
I guess we'll know what others thought of that by watching the share price over the next few weeks.
A disappointing short-term result. I had some (misplaced) optimism that the China market would be showing a more positive result for BLT by now. Despite that, I feel that things are still moving in the right direction, albeit as slowly as they always seem to with this company.
I've been on board with BLT since 2005 and like many others have suffered through the twists and turns, promises and let downs - but remain ever hopeful that the corner will be turned before too long. Sinopharm has nationwide distribution in China so if BLT product ticks the boxes for them then the trial with 600 pharmacies will be a mere drop in the ocean. Success with Sinopharm will be the catalyst for a major turnaround in the fortunes of BLT and its long-suffering shareholders.
Probably fair comment by the looks of it. But I expect it will likely come out in the wash. There wasn't any talk of market failure in any sense that I saw, more just a frustration that things are not going faster, particularly the functional food side perhaps. Or that's how I saw it, anyway. We'll have to do more waiting, as we've done before. Sigh. People who were looking for a quite short term increase in the share price may not be so pleased. This share certainly hasn't been for the impatient so far!
Hi Simla - if patience is a virtue - then we both must be extremely virtuous people. Looks like another year of waiting but 2015, the tenth anniversary of my initial share purchase, should be a year worth celebrating!
I expect we'll see a lower SP today as the impatient bail out.
During the period Sinopharm, the largest pharmaceutical and oral health company in China, sent representatives to visit the Dunedin operations and more recently BLIS management travelled to meet with Sinopharm and other key customers in China. Sinopharm has now commenced test-marketing of BLIS products across 600 pharmacies and will carry out three (3) clinical trials for BLIS products.
Blis have their foot in the door of one of the largest markets in the world.
What will Blis shares be worth if Sinopharm give the nod?
You giving your two cents worth then, Winner :)
I wonder if the mild sense of deflation in that report (that I saw anyway) was that they finally really do have their foot in the door of a whole lot of markets, having now battered through most regulations. But now the battle starts afresh with the whole need to keep pushing for momentum?
It seems cash flow must eventually turn their way, and most likely not that far away.But it must still be pretty wearying to just keep finding one more hill in front of them. I'm grateful for their energy.
The steady orders from Japan is something useful, anyway, with a population 32 times as big as NZ in just that one market. Plus my own internet searches suggest that maybe the Japanese are getting interested in giving this to their pets.
Released @ 4.52 pm last night. Classic sign of trouble (with a repeat this morning in case you want to double up on your bad news!)
*waits for classic "knocker" and "down ramper" comments*